Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-18

Clinical Trial Update: 8.4% Sodium Bicarbonate Locks in Intestinal Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring 8.4% sodium bicarbonate locks for preventing catheter-related bloodstream infections in intestinal failure patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 8.4% sodium bicarbonate locks (sodium bicarbonate)

Snippet

Sponsor: Riad Rahhal | Conditions: Intestinal Failure, CRBSI - Catheter Related Bloodstream Infection | Phase 2 | Status: UNKNOWN